Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Nektar Therapeutics
Scientific Title
A Phase 3, Randomized, Open-label Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)